Methicillin-resistant Staphylococcus aureus (MRSA) infection continues to be a substantial global problem with significant associated morbidity and mortality. This review summarises the discussions that took place at the 4th MRSA Consensus Conference in relation to the current treatment options for serious MRSA infections and how to optimise whichever therapy is embarked upon. It highlights the many challenges faced by both the laboratory and clinicians in the diagnosis and treatment of MRSA infections.
Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now? / Edwards, B; Andini, R.; Esposito, S.; Grossi, P.; Lew, D.; Mazzei, T.; Novelli, A.; Soriano, A.; Gould, I.M.. - In: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. - ISSN 2213-7165. - STAMPA. - 2:(2014), pp. 133-140. [10.1016/j.jgar.2014.03.009]
Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?
MAZZEI, TERESITA;NOVELLI, ANDREA;
2014
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) infection continues to be a substantial global problem with significant associated morbidity and mortality. This review summarises the discussions that took place at the 4th MRSA Consensus Conference in relation to the current treatment options for serious MRSA infections and how to optimise whichever therapy is embarked upon. It highlights the many challenges faced by both the laboratory and clinicians in the diagnosis and treatment of MRSA infections.
| File | Dimensione | Formato | |
|---|---|---|---|
|
JGAR - 2014.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
498.62 kB
Formato
Adobe PDF
|
498.62 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
